Pfizer Moves To Toss More Cases From Bextra MDL
Drug maker Pfizer Inc. has moved to throw out almost two dozen cases from the multidistrict litigation over its anti-inflammatory drugs Bextra and Celebrex, arguing the plaintiffs involved failed to comply...To view the full article, register now.
Already a subscriber? Click here to view full article